Migraine: Traditional or “Innovative” Treatment? A Preliminary Case-Control Study
- 25 June 2005
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 26 (3) , 231-233
- https://doi.org/10.1007/s00246-005-1006-4
Abstract
The aim of this preliminary case-control study was to compare, in patients with migraine and PFO, transcatheter closure of PFO vs. medical treatments. Twelve patients were treated with antimigraine drugs and twelve underwent percutaneous transcatheter closure. All patients were followed-up for 12 months. Our preliminary results seem to confirm that, compared to medical treatment, PFO closure is by far more effective in reducing both frequency, duration and intensity of migraine attacks. Furthermore, the occurrence of prodromal aura is almost abolished.Keywords
This publication has 20 references indexed in Scilit:
- Does Transcatheter Closure of Patent Foramen Ovale Really “Shut the Door?”Stroke, 2004
- Cerebral microembolism during transcatheter closure of patent foramen ovaleZeitschrift für Neurologie, 2004
- Migraine as a Risk Factor for Subclinical Brain LesionsJAMA, 2004
- Percutaneous Transcatheter Closure of Patent Foramen Ovale in Patients With Paradoxical EmbolismCirculation, 2002
- Detection of Right-to-Left Shunt with Ultrasound Contrast Agent and Transcranial Doppler SonographyCerebrovascular Diseases, 2000
- Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial)The American Journal of Cardiology, 1998
- An Update on the Epidemiology of MigraineHeadache: The Journal of Head and Face Pain, 1994
- Prevalence of Migraine Headache in the United StatesJAMA, 1992
- Epidemiology of headache in a general population—A prevalence studyJournal of Clinical Epidemiology, 1991
- MIGRAINE: A PULMONARY DISEASE ?The Lancet, 1972